Zannetti previously spent 21 years at Medtronic. She returns after serving as senior vice president of clinical research at Penumbra, where she helped drive the strategic and commercial business goals of the company as a member of the senior leadership team.
During Zannetti’s time at Medtronic, she played a pivotal role in establishing endovascular treatment options as a standard of care for abdominal and thoracic disease. She most recently served as vice president of clinical research and medical science for the Peripheral Vascular Health Operating Unit.
According to Medtronic, Zannetti earned her Doctor of Medicine, residency in general surgery, and fellowship in vascular surgery at the University of Perugia Medical School in Perugia, Italy. She completed a two-year research fellowship in vascular surgery at the Massachusetts General Hospital, Harvard Medical School in Boston, USA. The company notes that Zannetti’s extensive clinical experience will contribute significantly to Medtronic and Medtronic Aortic’s work to drive commercial excellence and develop life-saving treatments.
“After a great sixteen months at Penumbra where I worked alongside a fantastic team, I am excited to share that I am returning to Medtronic as general manager for the aortic business,” Zannetti shared on LinkedIn. “I look forward to going back to my roots where my career began 23 years ago and to work with my friends at Medtronic.”